Home|DSIJArticleDetail

Biocon subsidiary to Invest USD 56 Million in Syngene USA Inc for Biologics Facility Acquisition; DIIs increased their stake in last Quarter
Biocon subsidiary to Invest USD 56 Million in Syngene USA Inc for Biologics Facility Acquisition; DIIs increased their stake in last Quarter

Biocon subsidiary to Invest USD 56 Million in Syngene USA Inc for Biologics Facility Acquisition; DIIs increased their stake in last Quarter

With a PE ratio of 57.6x, the company trades at a premium compared to the industry PE of 46x. The company has ROCE of 14.7 per cent and ROE of 13.2 per cent.  

Prajwal Wakhare Article rating: 5.0
Syngene International : Creating New Benchmarks Through Top-Rated Research And Development
Syngene International : Creating New Benchmarks Through Top-Rated Research And Development

Syngene International : Creating New Benchmarks Through Top-Rated Research And Development

Ninad Ramdasi Article rating: 5.0

Looking ahead, the global market for research, development and manufacturing services in human and animal health, as well as specialty chemicals, are all showing promising growth. While there are many providers of specialist services, few companies offer the breadth of technology and capabilities that are available at Syngene International

DSIJ MINDSHARE

Mkt Commentary12-Mar, 2025

Mkt Commentary12-Mar, 2025

Penny Stocks12-Mar, 2025

Mindshare12-Mar, 2025

Mutual Fund12-Mar, 2025

Knowledge

Fundamental9-Mar, 2025

Technical8-Mar, 2025

Knowledge8-Mar, 2025

Understanding the Retail Debt Market

Understanding the Retail Debt Market

Debt securities are financial instruments like bonds or loans issued by companies or governments to raise...
DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

SEBI Registered Research Analyst Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INH000006396
Validity: Oct 05, 2018 - Perpetual
BSE Enlistment No. 5307

SEBI Registered Investment Adviser Details:
Registered Name: DSIJ PRIVATE LIMITED
Type of registration: Non-Individual
Registration No.: INA000001142
Validity: Aug 19, 2019 - Perpetual
BSE Enlistment No. 1346

Registered Address:
419-A, 4th floor, Arun Chambers,
Tardeo, Next to AC Market, Mumbai - 400 034.
Tel: +91 022-43476012/13/14/15 | Email: service@dsij.in
CIN No.: U22120MH2003PTC139276
GST No.: 27AACCR4303G1ZP

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR

Disclaimer: "Registration granted by SEBI, membership of BASL and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors"

Investment in securities market is subject to market risks. Read all the related documents carefully before investing.

Any act of copying, reproducing, or distributing the content whether wholly or in part, for any purpose without the permission of DSIJ is strictly prohibited and shall be deemed to be copyright infringement.

Disclosures | Terms & Conditions | Privacy Statement | WhiteList